GlassScriptPhysician profile
Clarkson M Driggers
NPI 1710973896
$953.01
in general payments reported to CMS, 2019-2025
12 companies · $375 in 2025
The $375 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.94 · 2022: $78.84 · 2023: $213 · 2024: $263 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $257.12 | 2023-2025 | Xifaxan, Plenvu |
| Intercept Pharmaceuticals, INC. | $144.21 | 2023-2024 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $127.83 | 2022-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $95.57 | 2022-2025 | Dupixent |
| Lilly USA, LLC | $91.53 | 2024-2025 | Omvoh, Zepbound |
| Janssen Biotech, INC. | $65.77 | 2023-2025 | Tremfya, Remicade, Simponi |
| Abbvie INC. | $51.22 | 2022-2024 | |
| Madrigal Pharmaceuticals | $32.59 | 2025 | Rezdiffra |
| Heron Therapeutics, INC. | $22.94 | 2021 | |
| Celltrion USA INC. | $22.47 | 2025 | Vegzelma |
| Ardelyx, INC. | $21.61 | 2024 | Ibsrela |
| Merck Sharp & Dohme LLC | $20.15 | 2024 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarkson Driggers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.